DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, is pleased to announce the appointment of Dr. Ling Su as President of the DIA Board of Directors. .
Dr. Su is Senior Vice President and Head of Development Greater China Region of Beijing Novartis Pharma Co., Ltd. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai. Dr. Su brings more than 20 years of experience to DIA, specifically in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmacovigillance, pharmacoepidemiology, and outcomes research.
“Through my years of service in the industry, as an active DIA volunteer for 20 years, and now as DIA Board President, I plan on sharing my insight to help DIA and the industry overcome the challenges that we collectively face,” says Dr. Su.
Dr. Su has served as chair of the DIA Provisional Advisory Council of China and received the DIA Outstanding Service Award in 2000.
Additional DIA Board members include:
- Minnie Baylor-Henry, JD, RPh President- Elect
- Yves Juillet, MD, Immediate Past President
- John A. Roberts, MBA, Treasurer
- Gesine Bejeuhr, PharmD
- Steve Caffe, MD
- Nancy A. Dreyer, PhD, MPH, FISPE
- Sergio Guerrero, MD
- Truus Janse-de Hoog, PharmD, MSc
- Tatsuo Kurokawa, PhD
- Michele C. Livesey, MBA
- Sandra A. Milligan, JD, MD
- Frances J. Richmond
- Jennifer L. Riggins, PharmD
- Larisa Nagra Singh, MPharm
- Per Spindler, DVM, MBA, MSc
- Beat E. Widler, PhD
- Ning Xu, MD,MBA
- Sandra L. Kweder, MD, FDA Liaison
DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org